CD163 Monoclonal Antibody Modified Polymer Prodrug Nanoparticles for Targeting Tumor-Associated Macrophages (TAMs) to Enhance Anti-Tumor Effects

Tumor-associated macrophages (TAMs)-based immunotherapy is a promising strategy. Since TAMs are mainly composed of M2-type macrophages, they have a promoting effect on tumor growth, invasion, and metastasis. M2-type macrophages contain a specific receptor CD163 on their surface, providing a prerequi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zun, Li, Haijiao, Zhang, Wenrui, Zhang, Mingzu, He, Jinlin, Yu, Zepeng, Sun, Xingwei, Ni, Peihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144748/
https://www.ncbi.nlm.nih.gov/pubmed/37111726
http://dx.doi.org/10.3390/pharmaceutics15041241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144748/
https://www.ncbi.nlm.nih.gov/pubmed/37111726
http://dx.doi.org/10.3390/pharmaceutics15041241

Ejemplares similares